Patent · US Active

Pegylated C-peptide

US8927488B2 · kind B2 · utility

0Cited by

40References

13Claims

0Family size

Assignee

Cebix, Inc.

Inventors

Sheri Barrack · Corte Madera, US
James Callaway · San Diego, US
Michelle Mazzoni · San Diego, US

Key dates

Filing date	May 17, 2011
Grant date	Jan 6, 2015
Priority date	—
Expiry date	May 17, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/62
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to modified forms of C-peptide, and methods for their use. In one aspect, the modified forms of C-peptide comprise PEGylated C-peptide derivatives comprising at least one PEG group attached to the N-terminus, which exhibit superior pharmacokinetic and biological activity in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.